INFECTIONS DUE TO ANTIBIOTIC-RESISTANT GRAM-POSITIVE COCCI

被引:10
作者
CAPUTO, GM
SINGER, M
WHITE, S
WEITEKAMP, MR
机构
关键词
D O I
10.1007/BF02599723
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Gram-positive cocci are becoming increasingly resistant to traditionally used antimicrobial agents. Staphylococcus aureus, coagulase-negative staphylococci, the enterococcus, and Streptococcus pneumoniae are the most commonly encountered of such pathogens in clinical practice. Clinicians should be keenly aware of the usual types of infections that are caused by these organisms and the importance of documenting susceptibilities of infecting strains. The basic mechanisms of resistance should be familiar to clinicians so that an inappropriate empiric regimen will not be selected (e.g., addition of a beta-lactamase inhibitor for penicillin-resistant pneumococci). Vancomycin remains the agent of choice, sometimes in combination with gentamicin and/or rifampin, for most cases of infection due to these resistant gram-positive organisms. Last, increased efforts toward prevention, such as strict adherence to infection control measures, selective use of broad-spectrum antibiotics, and increased use of pneumococcal vaccine, may be useful to help stem the rising tide of infections due to resistant gram-positive cocci. © 1993 Society of General Internal Medicine.
引用
收藏
页码:626 / 634
页数:9
相关论文
共 103 条
  • [1] Boyce J.M., Methicillin-resistant Staphylococcus aureus in nursing homes: putting the problem in perspective, Infect Control Hosp Epidemiol, 12, pp. 413-5, (1991)
  • [2] Boyce J.M., Methicillin-resistant Staphylococcus aureus: detection, epidemiology, and control measures, Infect Dis Clin North Am, 3, pp. 901-13, (1989)
  • [3] Craven D.E., Rixinger A.I., Goularte T.A., McCabe W.R., Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a “shooting gallery”, Am J Med, 80, pp. 770-6, (1986)
  • [4] Lyon B.R., Skurray R- Antimicrobial resistance of Staphyloccus aureus: genetic basis, Microbiol Rev, 51, pp. 88-134, (1987)
  • [5] Hartman B.M., Tomaz A., Low-affinity penicillin binding protein associated with beta-lactam resistance in Staphylococcus aureus, J Bacteriol, 158, (1984)
  • [6] Brumfitt W., Hamilton-Miller J., Methicillin-resistant Staphylococcus aureus, N Engl J Med, 320, pp. 1188-96, (1989)
  • [7] Wallace, Mascola J.R., Oldfield E.C., Red man syndrome: incidence, etiology, and prophylaxis, J Infect Dis, 164, pp. 1180-5, (1991)
  • [8] Levine D.P., Fromm B.S., Reddy B.R., Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis, Ann Intern Med, 115, pp. 674-80, (1991)
  • [9] Markowitz N., Quinn E.L., Savarolatz L.D., Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection, Ann Intern Med, 117, pp. 309-98, (1992)
  • [10] Blumberg H.M., Rimland D., Carrol D.J., Et al., Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus, J Infect Dis, 163, pp. 1279-85, (1991)